← All diseases
Cancer
Chronic lymphocytic leukemia
Would you like to receive a message when there is new research on Chronic Lymphocytic Leukemia? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a sentence above each publication explains what was studied — and you'll receive a notification as soon as there is new research about Chronic lymphocytic leukemia. View what Premium costs.
Publications and studies (1769)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Broadening the horizon: potential applications of CAR-T cells beyond current indications. (2023/11/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting BCL2 pathways in CLL: a story of resistance and ingenuity. (2023/11/27) ♡
- Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience. (2023/11/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent Updates in Venetoclax Combination Therapies in Pediatric Hematological Malignancies. (2023/11/24) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Response to therapy in Richter syndrome: a systematic review with meta-analysis of early clinical trials. (2023/11/23) ♡
- Characterization of Three Somatic Mutations in the 3'UTR of RRAS2 and Their Inverse Correlation with Lymphocytosis in Chronic Lymphocytic Leukemia. (2023/11/22) ♡
- [Clinical and molecular biological characterization of patients with accelerated chronic lymphocytic leukemia]. (2023/11/14) ♡
- [Advances in clinical research on novel BTK inhibitors for the treatment of chronic lymphocytic leukemia]. (2023/11/14) ♡
- An approach to anxiety during watch-and-wait for Chronic Lymphocytic Leukemia: Monitor and move on. (2023/11/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. [Long-term follow-up of humanized and murine CD19 CAR-T-cell therapy for B-cell acute lymphoblastic leukemia]. (2023/10/14) ♡
- ZNF683 marks a CD8(+) T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome. (2023/10/09) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pseudo-macrocytosis in chronic lymphocytic leukaemia. (2023/10/01) ♡
- Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL. (2023/09/28) ♡
- Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other Stimuli. (2023/09/25) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and cancer risk: A systematic review and meta-analysis. (2023/09/01) ♡
- Consumption of aspartame and other artificial sweeteners and risk of cancer in the Spanish multicase-control study (MCC-Spain). (2023/09/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Zanubrutinib for the treatment of chronic lymphocytic leukemia. (2023/09/01) ♡
- Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study. (2023/09/01) ♡
- Fecal acute phase proteins in cats with chronic enteropathies. (2023/09/01) ♡
- Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy. (2023/08/31) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acral Solitary Nodule as a First Clinical Manifestation of Chronic Lymphocytic Leukemia. (2023/08/31) ♡
- Tumor lysis syndrome followed by tumor regression after COVID-19 in a patient with chronic lymphocytic leukemia. (2023/08/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The dynamic functions of IRF4 in B cell malignancies. (2023/08/01) ♡
- A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting. (2023/07/31) ♡
- Using Human 'Personalized' Cybrids to Identify Drugs/Agents That Can Regulate Chronic Lymphoblastic Leukemia Mitochondrial Dysfunction. (2023/07/03) ♡
- Bendamustine-Rituximab in Young CLL: Relevance in the Era of Small Molecule Inhibitors. (2023/07/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia. (2023/07/01) ♡
- Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemia. (2023/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Bruton tyrosine kinase inhibitors: can they be optimized for the treatment of neuroinflammatory disorders? (2023/07/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Bizarre Progression Of Chronic Lymphocytic Leukaemia Into Diffuse Large B-Cell Lymphoma. (2023/07/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Molecular-Biology-Driven Frontline Treatment for Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Randomized Clinical Trials. (2023/06/09) ♡
- Relationships between T-lymphocytes and physical function in adults with chronic lymphocytic leukemia: Results from the HEALTH4CLL pilot study. (2023/06/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Ultra-processed food consumption and cancer risk: A systematic review and meta-analysis. (2023/06/01) ♡
- Determination of Venetoclax Concentration in Plasma Using High-Performance Liquid Chromatography. (2023/05/30) ♡
- Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study. (2023/05/30) ♡
- Association of tea-drinking habits with the risk of non-Hodgkin lymphoma: a prospective cohort study among postmenopausal women. (2023/05/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gas6/AXL pathway: immunological landscape and therapeutic potential. (2023/05/10) ♡
- NOTCH1 mutation in chronic lymphocytic leukaemia is associated with an enhanced cell cycle G1/S transition and specific cyclin overexpression: Preclinical ground for targeted inhibition. (2023/05/01) ♡
- A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry. (2023/04/01) ♡
- Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia. (2023/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The inherited genetic contribution and polygenic risk score for risk of CLL and MBL: a narrative review. (2023/04/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Long-term safety profile of tirabrutinib: final results of a Japanese Phase I study in patients with relapsed or refractory B-cell malignancies. (2023/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies. (2023/04/01) ♡
- Top advances of the year: Leukemia. (2023/04/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Optimal common limb length in Roux-en-Y gastric bypass surgery: is it important for an ideal outcome? - a systematic review. (2023/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature. (2023/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study. (2023/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Genetics and epigenetics of CLL. (2023/03/01) ♡
- Evaluation of cell collection efficiency in non-mobilized adult donors for autologous chimeric antigen receptor T-cell manufacturing. (2023/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Inotuzumab ozogamicin as a single agent to treat T315I-mutated chronic myeloid leukemia with acute blastic change to CD22+ acute lymphocytic leukemia. (2023/03/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.